3CARRATALA J, FERNANDEZ-SEVILLA A, TUBAU F, et al. Emergence of quinolone - resistant Escherichia coli bacteremia in neutrofamic patients with cancer who have received prophylactic norfloxacin[J]. Clin Infect Dis, 1995,20:557 - 560.
4GAFTER-GVILI A,FRASER A,PAUL M,et al. Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients[J]. Ann Intern Med 2005,142:979 - 995.
5BADEN L R. Prophylactic antimicrobial gents and the importance of fitness[J]. N Engl J Med, 2005,353 (10) : 1 052 - 1 054.
6BUCANEVE G, MIODZZI A, MENICHETTI F, et al. Levofloxaein to prevent bacterial infection in patients with cancer and neutropenia[J]. N Engl J Med,2005,353(10) :977 - 987.
7CULLEN M,STEVEN N,BILLINGHAM L,et al. Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas [J]. NEngl J Med, 2005,353 (10) : 988 - 998.
8MONNET D L,BIDDLE J W,EDWARDS J R,et al. Evidence of interhospital transmission of extended - spectrum beta - hctam - resistam Klebsiella pneumoniae in the United States, 1986 to 1993. The National Nosocomial Infections Surveillance System[J]. Infect Control Hosp Epidemiol, 1997.18(7) :492 - 498.
9OLSEN S J, DEBESS E E, MCGIVERN T E, et al. A nosocomial outbreak of fluoroquinolone- resistant salmondla infection[J]. N Engl J Med,2001,344:1 572- 1 579.
